Diamond Hill Capital Management LLC Investment Advisor Invests $31.64 Million in Equifax, Inc. $EFX

Diamond Hill Capital Management LLC Investment Advisor purchased a new stake in shares of Equifax, Inc. (NYSE:EFX - Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 199,342 shares of the credit services provider's stock, valued at approximately $31,640,000. Diamond Hill Capital Management LLC Investment Advisor owned about 0.17% of Equifax at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in EFX. Brighton Jones LLC grew its position in Equifax by 49.2% in the fourth quarter. Brighton Jones LLC now owns 3,638 shares of the credit services provider's stock worth $927,000 after acquiring an additional 1,200 shares in the last quarter. Great Lakes Advisors LLC bought a new position in shares of Equifax during the 1st quarter valued at $204,000. Empowered Funds LLC lifted its stake in shares of Equifax by 14.6% in the 1st quarter. Empowered Funds LLC now owns 2,523 shares of the credit services provider's stock valued at $615,000 after purchasing an additional 321 shares during the last quarter. First Trust Advisors LP boosted its holdings in Equifax by 14.5% in the second quarter. First Trust Advisors LP now owns 7,632 shares of the credit services provider's stock worth $1,979,000 after purchasing an additional 966 shares in the last quarter. Finally, AXA S.A. boosted its holdings in Equifax by 699.9% in the second quarter. AXA S.A. now owns 8,671 shares of the credit services provider's stock worth $2,249,000 after purchasing an additional 7,587 shares in the last quarter. Institutional investors and hedge funds own 96.20% of the company's stock.

Insider Buying and Selling

In related news, CEO Mark W. Begor sold 37,791 shares of the company's stock in a transaction on Friday, July 24th. The shares were sold at an average price of $172.16, for a total transaction of $6,506,098.56. Following the completion of the transaction, the chief executive officer directly owned 271,890 shares in the company, valued at $46,808,582.40. This represents a 12.20% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.70% of the stock is currently owned by insiders.

Equifax Stock Performance

EFX opened at $180.88 on Monday. The company has a quick ratio of 0.60, a current ratio of 0.60 and a debt-to-equity ratio of 0.92. The stock's 50 day moving average price is $169.94 and its two-hundred day moving average price is $178.54. The firm has a market capitalization of $21.25 billion, a P/E ratio of 31.79, a price-to-earnings-growth ratio of 1.45 and a beta of 1.30. Equifax, Inc. has a 12-month low of $150.74 and a 12-month high of $271.84.

Equifax (NYSE:EFX - Get Free Report) last issued its quarterly earnings results on Tuesday, July 21st. The credit services provider reported $2.25 EPS for the quarter, topping analysts' consensus estimates of $2.20 by $0.05. Equifax had a return on equity of 21.61% and a net margin of 10.73%.The company had revenue of $1.70 billion during the quarter, compared to analyst estimates of $1.70 billion. During the same period in the previous year, the company earned $2.00 earnings per share. The company's quarterly revenue was up 10.6% compared to the same quarter last year. Equifax has set its Q3 2026 guidance at 2.150-2.250 EPS and its FY 2026 guidance at 8.390-8.690 EPS. On average, equities analysts forecast that Equifax, Inc. will post 8.57 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. Mizuho cut their target price on Equifax from $222.00 to $210.00 and set an "outperform" rating on the stock in a report on Thursday, July 2nd. UBS Group reiterated a "buy" rating and set a $220.00 price target on shares of Equifax in a research note on Wednesday, July 8th. Morgan Stanley cut their price objective on Equifax from $243.00 to $225.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft set a $208.00 target price on Equifax in a report on Wednesday, July 22nd. Finally, Citigroup lowered their price target on Equifax from $256.00 to $238.00 and set a "buy" rating on the stock in a report on Wednesday, April 22nd. Thirteen research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $215.79.

About Equifax

Equifax Inc NYSE: EFX is a global data, analytics and technology company that specializes in consumer and commercial credit reporting, decisioning tools and identity solutions. Headquartered in Atlanta, Georgia, Equifax is one of the three major consumer credit reporting agencies in the United States and provides credit information and related services to lenders, employers, governments and consumers worldwide.

The company's offerings include consumer credit reports and scores, credit monitoring and identity protection services, and a range of business-oriented products for risk management, fraud detection and compliance.

Want to see what other hedge funds are holding EFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Equifax, Inc. (NYSE:EFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source